Literature DB >> 15086891

The pathobiology of chronic allograft nephropathy: immune-mediated damage and accelerated aging.

Simone A Joosten1, Cees van Kooten, Yvo W J Sijpkens, Johan W de Fijter, Leendert C Paul.   

Abstract

Chronic allograft nephropathy includes chronic calcineurin nephrotoxicity, recurrent and de novo glomerulonephritis and a group of disorders with graft dysfunction of unknown etiology designated chronic rejection. Review of risk factors of the latter category show that the chronic rejection lesions emerge in organs that have undergone injury. Despite the relevance of nonalloantigen-dependent progression factors in the tissue injury, alloantigen-dependent factors predominate in the pathogenesis. Lately, B cell responses have received increasing interest in transplant rejection and include responses against both major histocompatibility complex (MHC) and tissue-specific antigens, mainly on the endothelium and in the glomeruli. These humoral responses are thought to be involved in the development of vascular and glomerular lesions. Furthermore, at the tissue level, markers of senescence are found in the tubular epithelium contributing to the lesions of tubular atrophy and interstitial fibrosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15086891     DOI: 10.1111/j.1523-1755.2004.05410.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  7 in total

Review 1.  Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies.

Authors:  Chun-Feng Wang; Zhen-Yu Wang; Ji-Yu Li
Journal:  World J Gastroenterol       Date:  2011-07-14       Impact factor: 5.742

2.  Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.

Authors:  B D Modena; S M Kurian; L W Gaber; J Waalen; A I Su; T Gelbart; T S Mondala; S R Head; S Papp; R Heilman; J J Friedewald; S M Flechner; C L Marsh; R S Sung; H Shidban; L Chan; M M Abecassis; D R Salomon
Journal:  Am J Transplant       Date:  2016-03-15       Impact factor: 8.086

Review 3.  Pathogenesis and management of chronic allograft nephropathy.

Authors:  Serdar Yilmaz; Aylin Sar
Journal:  Drugs       Date:  2008       Impact factor: 9.546

4.  Mycophenolate mofetil and FK506 have different effects on kidney allograft fibrosis in rats that underwent chronic allograft nephropathy.

Authors:  Lei Luo; Zhaolin Sun; Weidong Wu; Guangheng Luo
Journal:  BMC Nephrol       Date:  2012-07-02       Impact factor: 2.388

5.  Effect of delayed graft function, acute rejection and chronic allograft dysfunction on kidney allograft telomere length in patients after transplantation: a prospective cohort study.

Authors:  Leszek Domański; Karolina Kłoda; Ewa Kwiatkowska; Ewa Borowiecka; Krzysztof Safranow; Arleta Drozd; Andrzej Ciechanowicz; Kazimierz Ciechanowski
Journal:  BMC Nephrol       Date:  2015-02-18       Impact factor: 2.388

Review 6.  Frailty in CKD and Transplantation.

Authors:  Elizabeth C Lorenz; Cassie C Kennedy; Andrew D Rule; Nathan K LeBrasseur; James L Kirkland; LaTonya J Hickson
Journal:  Kidney Int Rep       Date:  2021-06-09

Review 7.  Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug Targets.

Authors:  Adnan Bashir Bhatti; Muhammad Usman
Journal:  Cureus       Date:  2015-11-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.